Results 1 to 10 of about 1,389,538 (204)

Research Progress and Future Perspectives of Orexin Receptor Antagonists in Insomnia Therapy [PDF]

open access: yesMolecules
Insomnia is a common sleep disorder that significantly impairs quality of life and increases the risk of various chronic diseases. Although conventional sedative–hypnotic agents are effective, their clinical use is limited by tolerance, dependence, and ...
Zirui Zhang   +4 more
doaj   +3 more sources

On the kinetic features of orexin receptor antagonists at orexin receptors, transduction systems and receptor binding

open access: yesMedicine in Drug Discovery
Orexin receptor antagonists are on the market or under development for the treatment of insomnia and a number of other neuropsychiatric disorders. Currently, suvorexant, lemborexant and daridorexant, three dual orexin receptor antagonists (DORAs) have ...
Daniel Hoyer, Laura H. Jacobson
doaj   +4 more sources

Orexin receptor antagonists as therapeutic agents for insomnia [PDF]

open access: yesFrontiers in Pharmacology, 2013
Insomnia is a common clinical condition characterized by difficulty initiating or maintaining sleep, or non-restorative sleep with impairment of daytime functioning.Currently, treatment for insomnia involves a combination of cognitive behavioral therapy ...
Ana Clementina Equihua   +2 more
doaj   +5 more sources

Orexin, Orexin Receptor Antagonists and Central Cardiovascular Control [PDF]

open access: yesFrontiers in Neuroscience, 2013
Orexin makes an important contribution to the regulation of cardiovascular function. When injected centrally under anesthesia, orexin increases blood pressure, heart rate and sympathetic nerve activity.
Pascal eCarrive
doaj   +3 more sources

Beyond traditional sleeping pills: safety, efficacy and multidisease potential of three approved orexin receptor antagonists [PDF]

open access: yesFrontiers in Psychiatry
This is a narrative review aiming to summarize the latest research progress of orexin receptor antagonists in insomnia treatment. To review the latest research progress on orexin receptor antagonists in the treatment of sleep disorders and explore their ...
Zening Yang, Chenshuo Jia, Zhizhao Ma
doaj   +2 more sources

Orexin receptor antagonists attenuate acute stress-induced disruptions in sleep states [PDF]

open access: yesFrontiers in Neuroscience
Post-traumatic stress disorder (PTSD) is characterized by symptoms including hypervigilance, intrusive memories, and sleep disturbance. Insomnia and nightmares are among the most common and clinically important sleep-related symptoms in PTSD, yet ...
Kayla Lilly   +5 more
doaj   +2 more sources

Treatment of sleep‐related eating disorder with suvorexant: A case report on the potential benefits of replacing benzodiazepines with orexin receptor antagonists [PDF]

open access: yesPCN Reports, 2023
Background Nocturnal eating behavior in patients with sleep‐related eating disorder (SRED) is difficult to control and can become chronic, causing weight gain and psychological distress.
Kentaro Matsui   +4 more
doaj   +2 more sources

Pharmacological modulation of hyperarousal in insomnia associated with major depressive disorder: a narrative review of sedating antidepressants and orexin receptor antagonists [PDF]

open access: yesFrontiers in Psychiatry
Insomnia symptoms in major depressive disorder (MDD) are clinically heterogeneous, ranging from presleep rumination and prolonged sleep latency to repeated nocturnal awakenings and early-morning awakening.
Yiwei Zhang   +7 more
doaj   +2 more sources

Orexin receptor antagonists reverse aberrant dopamine neuron activity and related behaviors in a rodent model of stress-induced psychosis [PDF]

open access: yesTranslational Psychiatry, 2021
Post-traumatic stress disorder (PTSD) is a prevalent condition affecting approximately 8% of the United States population and 20% of United States combat veterans. In addition to core symptoms of the disorder, up to 64% of individuals diagnosed with PTSD
Hannah B. Reiley   +3 more
doaj   +2 more sources

Slumber’s Duel: The Upstart Orexin Receptor Antagonists Versus the Battle-Hardened Z-Drugs: Systematic Review and Meta-Analysis Unveiling a Tale of Efficacy and Safety of Two Contenders [PDF]

open access: yesBJPsych Open
Aims: Primary insomnia, a separate diagnosis that is now included within the newly broader categorization of insomnia, greatly affects the quality of life.
Asha Devi Dhandapani   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy